Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

bausch health us, llc - hydrocortisone butyrate (unii: 05rmf7ypwn) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone butyrate 1 mg in 1 ml - locoid (hydrocortisone butyrate) solution, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of seborrheic dermatitis. none.

Малта - Енглески - Medicines Authority

leo pharma a/s industriparken 55, 2750-dk ballerup, denmark - hydrocortisone butyrate - cutaneous solution - hydrocortisone butyrate 1 mg/g - corticosteroids, dermatological preparations

Малта - Енглески - Medicines Authority

leo pharma a/s industriparken 55, 2750-dk ballerup, denmark - hydrocortisone butyrate - ointment - hydrocortisone butyrate 1 mg/g - corticosteroids, dermatological preparations

Малта - Енглески - Medicines Authority

leo pharma a/s industriparken 55, 2750-dk ballerup, denmark - hydrocortisone butyrate - cream - hydrocortisone butyrate 1 milligram(s)/gram - corticosteroids, dermatological preparations

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

bausch health us, llc - hydrocortisone butyrate (unii: 05rmf7ypwn) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone butyrate 1 mg in 1 ml - locoid® lotion is indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. none. pregnancy   risk summary there are no controlled or large-scale epidemiologic studies with locoid lotion in pregnant women, and available data on hydrocortisone butyrate use in pregnant women have not identified a drug associated risk for major birth defects, miscarriages, or adverse maternal or fetal outcomes. in animal reproduction studies, when administered subcutaneously or topically to pregnant rats, rabbits, and mice, hydrocortisone butyrate induced adverse reproductive and developmental outcomes, including abortion, fetal death, malformation, delayed ossification, decrease in fetal weight, and delay in sexual maturation (see data) . the available data do not allow the calculation of relevant comparisons between the systemic exposure of hydrocortisone butyrate observed in animal studies and the systemic exposure that would be expected in humans after topical use of lo

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

pco manufacturing - hydrocortisone butyrate - cream - 0.1 %w/w

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - hydrocortisone butyrate 0.1%;   - scalp lotion - 0.1 % - active: hydrocortisone butyrate 0.1%   excipient: citric acid glycerol isopropyl alcohol povidone purified water sodium citrate

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - hydrocortisone butyrate 0.1%;   - topical ointment - 0.1 % - active: hydrocortisone butyrate 0.1%   excipient: liq. paraf. gel with 5% poyethylene oleogel to 100%.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - hydrocortisone butyrate 0.1%{relative} (1.5% overage);   - topical emulsion - 0.1% w/w - active: hydrocortisone butyrate 0.1%{relative} (1.5% overage)   excipient: borage oil butyl hydroxybenzoate butylated hydroxytoluene cetomacrogol cetostearyl alcohol citric acid hard paraffin propyl hydroxybenzoate propylene glycol purified water sodium citrate dihydrate white soft paraffin

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

pco manufacturing - hydrocortisone butyrate - cream - 0.1 %w/w